Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NGFR antisense RNA 1 (NGFR-AS1) is a long non-coding RNA (lncRNA) that is transcribed in the antisense direction relative to the nerve growth factor receptor (NGFR) gene. Antisense lncRNAs like NGFR-AS1 can regulate the expression of their corresponding sense gene (here, NGFR) through diverse mechanisms, such as recruiting chromatin-modifying enzymes, affecting local epigenetic status, or directly binding to sense mRNA to influence its stability or translation[1][2]. Though the role of NGFR-AS1 is not yet extensively characterized, the regulatory functions of antisense lncRNAs in modulating gene expression have been well described, especially in cancer, where they participate in proliferation, invasion, migration, and epigenetic regulation[1][2]. There is limited information directly implicating NGFR-AS1 as a therapeutic target or biomarker; its functional roles are inferred based on the broader activities of antisense lncRNAs in gene regulation[1][2]. Thus, NGFR-AS1 is primarily classified as a regulatory non-coding RNA rather than a conventional therapeutic target like a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NGFR antisense RNA 1 (NGFR-AS1).